Literature DB >> 23507202

Phosphatidic acid and lipid-sensing by mTOR.

David A Foster1.   

Abstract

Mammalian target of rapamycin (mTOR) has been implicated as a sensor of nutrient sufficiency for dividing cells and is activated by essential amino acids and glucose. However, cells also require lipids for membrane biosynthesis. A central metabolite in the synthesis of membrane phospholipids is phosphatidic acid (PA), which is required for the stability and activity of mTOR complexes. Although PA is commonly generated by the phospholipase D-catalyzed hydrolysis of phosphatidylcholine, PA is also generated by diacylglycerol kinases and lysophosphatidic acid acyltransferases, which are at the center of phospholipid biosynthesis. It is proposed that the responsiveness of mTOR/TOR to PA evolved as a means for sensing lipid precursors for membrane biosynthesis prior to doubling the mass of a cell and dividing.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507202      PMCID: PMC3669661          DOI: 10.1016/j.tem.2013.02.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  74 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

2.  The phospholipase D1 pathway modulates macroautophagy.

Authors:  Claudia Dall'Armi; Andrés Hurtado-Lorenzo; Huasong Tian; Etienne Morel; Akiko Nezu; Robin B Chan; W Haung Yu; Kimberly S Robinson; Oladapo Yeku; Scott A Small; Karen Duff; Michael A Frohman; Markus R Wenk; Akitsugu Yamamoto; Gilbert Di Paolo
Journal:  Nat Commun       Date:  2010       Impact factor: 14.919

3.  Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s).

Authors:  David A Foster; Paige Yellen; Limei Xu; Mahesh Saqcena
Journal:  Genes Cancer       Date:  2010-11

4.  Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid.

Authors:  Antonia Avila-Flores; Teresa Santos; Esther Rincón; Isabel Mérida
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

5.  Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway.

Authors:  Wenwen Tang; Jian Yuan; Xinya Chen; Xiuting Gu; Kuntian Luo; Jie Li; Bo Wan; Yingli Wang; Long Yu
Journal:  J Biochem Mol Biol       Date:  2006-09-30

6.  PERK utilizes intrinsic lipid kinase activity to generate phosphatidic acid, mediate Akt activation, and promote adipocyte differentiation.

Authors:  Ekaterina Bobrovnikova-Marjon; Dariusz Pytel; Matthew J Riese; Laura Pontano Vaites; Nickpreet Singh; Gary A Koretzky; Eric S Witze; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2012-04-09       Impact factor: 4.272

7.  Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.

Authors:  Robert Lavieri; Sarah A Scott; Jana A Lewis; Paige E Selvy; Michelle D Armstrong; H Alex Brown; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2009-03-06       Impact factor: 2.823

Review 8.  Amino acid regulation of TOR complex 1.

Authors:  Joseph Avruch; Xiaomeng Long; Sara Ortiz-Vega; Joseph Rapley; Angela Papageorgiou; Ning Dai
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-02       Impact factor: 4.310

9.  Defective TGF-beta signaling sensitizes human cancer cells to rapamycin.

Authors:  N Gadir; D N Jackson; E Lee; D A Foster
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

10.  Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.

Authors:  Alfredo Toschi; Evan Lee; Limei Xu; Avalon Garcia; Noga Gadir; David A Foster
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

View more
  45 in total

1.  Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids.

Authors:  Maria A Frias; Suman Mukhopadhyay; Elyssa Lehman; Aleksandra Walasek; Matthew Utter; Deepak Menon; David A Foster
Journal:  J Biol Chem       Date:  2019-11-24       Impact factor: 5.157

Review 2.  The Enigma of Rapamycin Dosage.

Authors:  Suman Mukhopadhyay; Maria A Frias; Amrita Chatterjee; Paige Yellen; David A Foster
Journal:  Mol Cancer Ther       Date:  2016-02-25       Impact factor: 6.261

3.  Topography design in model membranes: Where biology meets physics.

Authors:  Sarina Chand; Paul Beales; Frederik Claeyssens; Barbara Ciani
Journal:  Exp Biol Med (Maywood)       Date:  2018-10-31

4.  Reciprocal regulation of AMP-activated protein kinase and phospholipase D.

Authors:  Suman Mukhopadhyay; Mahesh Saqcena; Amrita Chatterjee; Avalon Garcia; Maria A Frias; David A Foster
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

5.  Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.

Authors:  Estibaliz González de San Román; Iván Manuel; María Teresa Giralt; Jerold Chun; Guillermo Estivill-Torrús; Fernando Rodríguez de Fonseca; Luis Javier Santín; Isidro Ferrer; Rafael Rodríguez-Puertas
Journal:  J Neurochem       Date:  2015-04-27       Impact factor: 5.372

6.  DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN-WEE1 Signaling.

Authors:  Jie Li; Chaoyun Pan; Austin C Boese; JiHoon Kang; Anna D Umano; Kelly R Magliocca; Wenqing Yang; Yu Zhang; Sagar Lonial; Lingtao Jin; Sumin Kang
Journal:  Clin Cancer Res       Date:  2020-04-27       Impact factor: 12.531

7.  A Repertoire of MicroRNAs Regulates Cancer Cell Starvation by Targeting Phospholipase D in a Feedback Loop That Operates Maximally in Cancer Cells.

Authors:  Kristen Fite; Lobna Elkhadragy; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2016-01-19       Impact factor: 4.272

8.  Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin.

Authors:  Darin Salloum; Suman Mukhopadhyay; Kaity Tung; Aleksandra Polonetskaya; David A Foster
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

Review 9.  Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).

Authors:  David A Foster; Darin Salloum; Deepak Menon; Maria A Frias
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

10.  5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cells.

Authors:  Suman Mukhopadhyay; Amrita Chatterjee; Diane Kogan; Deven Patel; David A Foster
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.